1. Home
  2. ATPC vs NSPR Comparison

ATPC vs NSPR Comparison

Compare ATPC & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATPC
  • NSPR
  • Stock Information
  • Founded
  • ATPC 2016
  • NSPR 2005
  • Country
  • ATPC Malaysia
  • NSPR United States
  • Employees
  • ATPC N/A
  • NSPR N/A
  • Industry
  • ATPC Medical/Nursing Services
  • NSPR Medical/Dental Instruments
  • Sector
  • ATPC Health Care
  • NSPR Health Care
  • Exchange
  • ATPC Nasdaq
  • NSPR Nasdaq
  • Market Cap
  • ATPC 68.0M
  • NSPR 74.8M
  • IPO Year
  • ATPC N/A
  • NSPR N/A
  • Fundamental
  • Price
  • ATPC $1.26
  • NSPR $2.50
  • Analyst Decision
  • ATPC
  • NSPR Strong Buy
  • Analyst Count
  • ATPC 0
  • NSPR 2
  • Target Price
  • ATPC N/A
  • NSPR $4.50
  • AVG Volume (30 Days)
  • ATPC 52.7K
  • NSPR 109.7K
  • Earning Date
  • ATPC 08-13-2025
  • NSPR 08-05-2025
  • Dividend Yield
  • ATPC N/A
  • NSPR N/A
  • EPS Growth
  • ATPC N/A
  • NSPR N/A
  • EPS
  • ATPC N/A
  • NSPR N/A
  • Revenue
  • ATPC $1,445,601.00
  • NSPR $7,066,000.00
  • Revenue This Year
  • ATPC N/A
  • NSPR $4.85
  • Revenue Next Year
  • ATPC N/A
  • NSPR $113.47
  • P/E Ratio
  • ATPC N/A
  • NSPR N/A
  • Revenue Growth
  • ATPC 4.90
  • NSPR 7.60
  • 52 Week Low
  • ATPC $0.90
  • NSPR $1.99
  • 52 Week High
  • ATPC $3.49
  • NSPR $3.80
  • Technical
  • Relative Strength Index (RSI)
  • ATPC 42.36
  • NSPR 51.38
  • Support Level
  • ATPC $1.20
  • NSPR $2.37
  • Resistance Level
  • ATPC $1.39
  • NSPR $2.60
  • Average True Range (ATR)
  • ATPC 0.07
  • NSPR 0.19
  • MACD
  • ATPC -0.00
  • NSPR -0.01
  • Stochastic Oscillator
  • ATPC 25.00
  • NSPR 25.86

About ATPC Agape ATP Corporation

Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs. Its segments include: Skin care, health and wellness segment includes the provision of health and wellness products and health solution advisory services; and Green energy segment includes providing renewable energy products, technical solutions, installations and maintenance services. It derives maximum revenue from Skin care, health and wellness segment.

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

Share on Social Networks: